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terms of cosmetic results, 99% and 1% of patients considered 
the result as good/excellent and as fair after RT, 
respectively. No patients had a poor cosmetic outcome. 
 
Conclusion: These results support the feasibility and good 
tolerability of SIB-VMAT in elderly patients with a diagnosis of 
breast cancer following CS with acceptable acute and late 
treatment-related toxicity. These preliminary results 
justified continuing the clinical study with the goal to 
establish the impact of hypofractionated SIB-VMAT in elderly 
patients with diagnosis of early stage breast cancer.  
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Purpose or Objective: To investigate the pathogenesis of 
peri-prosthesic capsule contraction (CCPP) related to post 
mastectomy radiotherapy in breast cancer patients 
undergoing breast reconstruction with heterologous material. 
 
Material and Methods: Patients developing (early or late) 
CCPP after breast reconstruction were enrolled in this study. 
CCPP was clinically evaluated by Baker score in order to 
define pain, rigidity, firmness and dislocation of implant. 
CCPP was analysed considering pathological aspect after sub-
total capsulectomy with anterior removal of peri-prosthesic 
capsule. Patients were split into two groups according to 
radiotherapy administration. Group 1 accounted for 
irradiated patients (50 Gy, 2 Gy per fraction on chest wall, 
using tangential field-in-field technique). Group 2 included 
not irradiated patients. Baker Score and microscopic 
observation (simil-synovial reaction, hyalinosis, vascular 
reaction, giant cells) of the two groups were compared by 
univariate and multivariate analysis. 
 
Results: Analysis was performed on 26 patients who 
developed CCPP (29 capsulectomy, because 3 bilateral) in the 
period between April 2012 and February 2015 (34 months). 
All patients developed CCPP within 1 year from first 
reconstructive surgery. Characteristics of both groups are 
reported in Table 1. 
 
Univariate analysis showed a positive association between 
Baker Score and radiotherapy (OR: 1.65), and hyalinosis and 
radiotherapy (OR: 1.2). Multivariate analysis confirmed 
association between CCPP and radiotherapy (OR: 17.9); 
chemotherapy (OR: 4.3) and hormone therapy (OR: 48.44) in 
terms of contraction grade and simil-synovial reactions 
respectively. 
 
Conclusion: Radiotherapy after breast reconstruction 
significantly influenced onset and severity of CCPP, although 
other variables contributed to CCPP multifactorial aetiology. 
In particular, hormone therapy and chemotherapy played a 
role in modifying capsular architecture. 
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Purpose or Objective: Evaluation of radiation- induced 
morbidity is routinely done as an integrated part of 
treatment response follow-up, and can be scored according 
to clinical assessment tools such as the CTCAE or LENT-SOMA. 
Objective measures in this evaluation would be valuable 
given their quantitative nature, facilitating comparison 
across cohorts and treatment institutions. High-frequency 
ultrasound (US) is a high-precision, objective tool to measure 
dermis thickness of the skin. We aimed to analyze dermis 
thickness in a cohort of women following radiotherapy (RT) 
for breast cancer with various grades of induration and 
edema. 
 
Material and Methods: The cohort was recruited from the 
DBCG HYPO/PBI RT protocols and comprised 15 women 
treated for early breast cancer during 2009–2013 with 
lumpectomy and RT 50 or 40 Gy +/- systemic therapy. 
Clinical morbidity follow-up of induration and edema was 
done at baseline and annually according to the LENT-SOMA 
scale. Dermis thickness was measured in mm using high-
frequency US. Points of measurement were 3 cm from the 
areola in four quadrants in both irradiated and contralateral 
non-irradiated breasts. Differences in mean dermis 
thicknesses were tested by two-tailed paired t-test. The US 
scanner utilized was a high-resolution 20 MHz DermaScan® C 
from Cortex Technology ApS. This device is optimized for 
recognizing structures at 60 µm, corresponding to tissue 
microstructures sized like collagenous fibres. 
 
Results: Median follow-up time was 3.0 years (range 1.0 – 
4.6). Overall, mean dermis thicknesses were 2.22 mm (1.78 -
2.66) in the irradiated (I) breast and 1.26 mm (95% CI: 1.08 - 
1.44) in the contralateral (C) breast. Mean difference 
between breasts was 0.96 mm (0.49 - 1.43, p<0.001). Dermis 
thickness was distributed in quadrants as follows: Lower 
lateral I: 2.62 (1.92 – 3.31) C: 1.11 (0.96 - 1.26), lower 
medial I: 2.64 (2.06 – 3.21) C: 1.45 (1.18 - 1.72), upper 
lateral I: 1.55 (1.33 – 1.78) C: 1.17 (1.01 – 1.34), upper 
medial I: 2.08 (1.49 – 2.67) C: 1.31 (1.09 – 1.53). In patients 
without clinical edema, the mean difference in dermis 
thickness for grade 1 induration was 0.35 mm (-0.46 - 1.16, 
p=0.21) and for grade 2 induration 0.71 mm (-0.01 - 1.43, 
p>0.05). In patients with clinical edema, only one patient had 
grade 1 induration (dermis thickness difference 1.34 mm). In 
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patients with clinical edema and grade 2 induration, mean 
difference in dermis thickness was 1.61 mm (0.27 - 2.95, 
p=0.03). Edema was associated with a more diffuse signal and 
an indistinct demarcation against the subcutaneous tissue. 
This was more pronounced in the lower quadrants (Figure). 
 
Conclusion: High-frequency US has potential to measure 
increased dermis thickness associated with radiation-induced 
induration in breast cancer patients. Edema may increase 
dermis thickness and lead to a more diffuse US signal. 
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Purpose or Objective: Ductal carcinoma in situ (DCIS) 
represents around 20% of breast cancers (BC). Standard 
treatment after breast conserving surgery is still adjuvant 
radiotherapy (RT). Several randomized trials and meta-
analysis showed a 50% risk reduction in LR after adjuvant RT. 
The aim of our analysis was to evaluate the LR rate and 
possibly to identify a risk groups stratification for DCIS 
treatment optimization. 
 
Material and Methods: We analyzed 457 patients that 
underwent BCS and adjuvant RT between 1990 and 2012. 
Median dose to the whole breast was 50 Gy in 25 fractions; 
patients with positive/close final surgical margins received a 
tumor bed boost. We stratified patients in low risk group 
using well known risk factor for LR (n=203; age ≥50 years, 
surgical margins ≥10 mm, nuclear grade 1 -2, pT ≤25 mm), 
and intermediate-high risk group (n=254; age <50 years, 
surgical margins <10 mm, nuclear grade 3 or pT >25 mm). We 
performed also a patient startification according to Van Nuys 
Prognostic Index. Estrogen and progesterone receptors 
status, nuclear grade, and Ki-67 proliferative index were 
available for most patients. 
 
Results: The mean age was 57 years (range 33-80). Hormonal 
status was positive in 92% of patients, 83 cases (18.2%) 
received adjuvant endocrine therapy. All patients received 
postoperative RT, 198 cases (43%) received also a RT boost on 
tumor bed. 
At a median follow up time of 12 years (range 3-23), we 
observed 26 LR (5.6%). Following risk groups stratification, 
we observed seven LR (3.4%) in low risk group and nineteen 
LR (7.4%) in intermediate-high risk group (p<0.001). 
 
Conclusion: Our experience evidenced a significant 
difference in LR incidence after adjuvant RT based on our 
risk factors stratification. 
This confirms the wide heterogeneity of DCIS. Identification 
of clear subgroups of patients following risk factors is still 
lacking. Waiting for results from ongoing clinical phase 3 
trials and genomic studies, postoperative RT still remains a 
mainstay in adjuvant treatment for DCIS. 
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Purpose or Objective: Voluntary moderate deep inspiration 
breath-hold (vmDIBH) is widely used for patients with left 
sided breast cancer. The purpose of this study was to 
investigate the utility of vmDIBH in local and locoregional 
radiation therapy (RT) for patients with right-sided breast 
cancer. 
 
Material and Methods: For fourteen patients with right-sided 
breast cancer, forward IMRT plans were calculated on free-
breathing (FB) and vmDIBH CT-scans, for local- as well as 
locoregional breast treatment, with and without internal 
mammary lymph nodes (IMN). We compared dose volume 
parameters to estimate the reduction in the risk of radiation 
pneumonitis, the influence on pulmonary lung function tests 
and the risk of secondary lung cancer with the use of 
vmDIBH. 
 
Results: For local breast treatment, no relevant reduction in 
mean lung dose (MLD) was found. For locoregional breast 
treatment without IMN, the average MLD reduced from 6.5 to 
5.4 Gy (p<0.005) for the total lung and from 11.2 to 9.7 Gy 
(p<0.005) for the ipsilateral lung. For locoregional breast 
treatment with IMN, the average MLD reduced from 10.8 to 
9.1 Gy (p<0.005) for the total lung and from 18.7 to 16.2 Gy 
(p<0.005) for the ipsilateral lung. We also found a reduction 
in mean heart dose between 0.6 and 2.6 Gy in four patients; 
with a mean of 0.4 Gy for all 14 patients together (p=0.07). 
We estimate that 1 out of 100 patients will not develop 
radiation pneumonitis when breath-hold is applied during 
locoregional right-sided breast cancer treatment. For ever-
smoking women, the risk of secondary lung cancer might also 
be reduced by vmDIBH.  
 
 
 
Conclusion: Breathing adapted radiation therapy in patients 
with left-sided breast cancer is becoming widely introduced. 
As a result of the slight reduction in lung dose found for 
